Oxidation of low-density lipoproteins produces levuglandin-protein adducts

Chemical Research in Toxicology

Volumn 10, Issue 7, 1997, Pages 750-759

  Salomon, Robert G ^a   Subbanagounder, Ganesamoorthy ^a   Singh, Upinder ^a   O'Neil, June ^b   Hoff, Henry F ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVUGLANDIN E2; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE A2;

ARTICLE; ATHEROGENESIS; CHEMICAL STRUCTURE; COMPLEX FORMATION; LIPID OXIDATION; MOLECULAR INTERACTION;

CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREE RADICALS; HUMANS; LIPOPROTEINS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; PHOSPHATIDYLCHOLINES; PROSTAGLANDINS E; SERUM ALBUMIN;

EID: 0030788494     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx970016b     Document Type: Article

References (47)

1. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., and Witztum, J. L. (1989) Beyond Cholesterol. Modifications of low-density lipoprotein that increase its atherogenity. N. Engl. J. Med. 320, 915-924.
2. Parthasarathy, S., Steinberg, D., and Witztum, J. L. (1992) The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu. Rev. Med. 43, 219-225.
3. Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., and Steinberg, D. (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. U.S.A. 81, 3883-3887.
4. Steinbrecher, U. P., Witztum, J. L., Parthasarathy, S., and Steinberg, D. (1987) Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Atherosclerosis 7, 135-143.
5. Esterbauer, H., Jürgens, G., Quehenberger, O., and Koller, E. (1987) Autooxidation of low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 28, 495-509.
6. Esterbauer, H., Gebicki, J., Puhl, H., and Jürgens, G. (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Biol. Med. 13, 341-390.
7. Fogelman, A. M., Shechter, I., Seager, J., Hokom, M., Child, J. S., and Edwards, P. A. (1980) Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc. Natl. Acad. Sci. U.S.A. 77, 2214-2218.
8. Jürgens, G. J., Lang, J., and Esterbauer, H. (1986) Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. Biochim. Biophys. Acta 875, 103-114.
9. Morrow, J. D., Harris, T. M., and Roberts, L. J., II (1990) Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184, 1-10.
10. Nugteren, D. H., and Hazelhof, E. (1973) Isolation and properties of intermediates in prostaglandin biosynthesis. Biochim. Biophys. Acta 326, 448-461.
11. Hamberg, M., Svensson, J., Wakabayashi, T., and Samuelsson, B. (1974) Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc. Natl. Acad. Sci. U.S.A. 71, 345-349.
12. 2. Adv. Prostaglandin Thromboxane Res. 6, 129-137.
13. 2 and a novel intramolecular 1,2-hydride shift during endoperoxide fragmentation in aqueous solution. J. Am. Chem. Soc. 106, 6049-6060.
14. Fishman, R. A., and Chan, P. H. (1981) Hypothesis: membrane phospholipid degradation and polyunsaturated fatty acids play a key role in the pathogenesis of brain edema. Trans. Am. Neurol. Assoc. 106, 58-61.
15. Siesjö, B. K., and Wieloch, T. (1983) Fatty acid metabolism and the mechanisms of ischemic brain damage. In Cerebrovascular Diseases (Reivich, M., and Hurtig, H., Eds.) pp 251-274, Raven, New York.
16. 2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J. Clin. Invest. 93, 998-1004.
17. 2 with proteins. Prostaglandins 34, 643-656.
18. 2 with proteins. J. Org. Chem. 59, 6038-6043.
19. Jackson, A. H. (1980) Pyrroles. In Comprehensive Organic Chemistry (Barton, D., and Ollis, D. W., Eds.) Vol. 4, pp 275-320, Pergamon, New York.
20. Steinbrecher, U. P., and Pritchard, P. H. (1989) Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. J. Lipid Res. 30, 305-315.
21. 2 activity of apolipoprotein B-100. Proc. Natl. Acad. Sci. U.S.A. 87, 9741-9745.
22. 2 activities. FEBS Lett. 315, 267-270.
23. Steinbrecher, U. P. (1987) Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262, 3603-3608.
24. 2. J. Org. Chem. 55, 3164-3175.
25. 2-protein adducts in human plasma and vasculature. Chem. Res. Toxicol. 10, 536-545.
26. Hébert, N., Beck, A., Lennox, R. B., and Just, G. (1992) A new reagent for the removal of the 4-methoxybenzyl ether: application to the synthesis of unusual macrocyclic and bolaform phosphati-dylcholines. J. Org. Chem. 57, 1777-1783.
27. Hatch, F. T., and Lees, R. S. (1968) Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 6, 1-68.
28. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Measurements of protein using bicinchonic acid. Anal. Biochem. 150, 76-85. See also BCA Protein Assay Reagent Instructions, Pierce, Rockford, IL 61105.
29. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Measurements of protein using bicinchonic acid. Anal. Biochem. 150, 76-85. See also BCA Protein Assay Reagent Instructions, Pierce, Rockford, IL 61105.
30. Berger, H. J., Zaret, B. L., Speroff, L., Cohen, L. S., and Wolfson, S. (1977) Cardiac prostaglandin release during myocardial ischemia induced by atrial pacing in patients with coronary artery disease. Am. J. Cardiol. 39, 481-486.
31. Hsueh, W., and Needleman, P. (1978) Sites of lipase activation and prostaglandin synthesis in isolated, perfused rabbit hearts and hydronephortic kidneys. Prostaglandins 16, 661-681.
32. Gaudet, R. J., and Levine, L. (1979) Transient cerebral ischemia and brain prostaglandins. Biochem. Biophys. Res. Commun. 86, 893-901.
33. Gaudet, R. J., Alam, I., and Levine, L. (1980) Accumulation of cyclooxygenase products of arachidonic acid metabolism in gerbil brain during reperfusion after bilateral common carotid artery occlusion. J. Neurochem. 35, 653-658.
34. Hirsh, P. D., Hillis, L. D., Campbell, W. B., Firth, B. G., and Willerson, J. T. (1981) Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N. Engl. J. Med. 304, 685-691.
35. Roberts, L. J., II, and Morrow, J. D. (1994) Isoprostanes. Novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury. Ann. N. Y. Acad. Sci. 744, 237-242.
36. Mathews, W. R., Guido, D. M., Fisher, M. A., and Jaeschke, H. (1994) Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemia. Free Rad. Biol. Med. 16, 763-770.
37. Wells, M. A., and Hanahan, D. J. (1969) Phospholipase A from Crotalus adamanteus venom. Methods Enzymol. 14, 178-184.
38. Esterbauer, H., Dieber-Rotheneder, M., Waeg, G., Striegl, G., and Jürgens, G. (1990) Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem. Res. Toxicol. 3, 77-92.
39. Ylä-Herttuala, S., Jaakkola, O., Ehnholm, C., Tikkanen, M. J., Solakivi, T., Särkioja, T., and Nikkari, T. (1988) Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. J. Lipid Res. 29, 563-572.
40. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. U.S.A. 87, 9383-9387.
41. Morrow, J. D., Minton, R. A., Mukundan, C. R., Campbell, M. D., Zackert, W. E., Daniel, V. C., Badr, K. F., Blair, I. A., and Roberts, L. J., II (1994) Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes. J. Biol. Chem. 269, 4317-4326.
42. Salomon, R. G. (1985) Prostaglandin endoperoxide reaction mechanisms and the discovery of levuglandins. Acc. Chem. Res. 18, 294-301.
43. 2. Presented at the Division of Organic Chemistry, 211th National American Chemical Society Meeting, New Orleans, LA.
44. 2 crosslinks proteins. Prostaglandins 37, 471-480.
45. 2-protein adducts bind glycine: a model for protein crosslinking. Prostaglandins 40, 187-203.
46. 2. Biochemistry 32, 4090-4097.
47. 2, an oxidation product of arachidonic acid. Biochim. Biophys. Acta 1344, 1-5.